Wedge Capital Management L L P NC increased its holdings in Genpact Limited (NYSE:G – Free Report) by 6.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,179 shares of the business services provider’s stock after buying an additional 2,830 shares during the quarter. Wedge Capital Management L L P NC’s holdings in Genpact were worth $1,983,000 at the end of the most recent reporting period.
Other large investors also recently added to or reduced their stakes in the company. Sawyer & Company Inc boosted its holdings in Genpact by 2.7% in the 4th quarter. Sawyer & Company Inc now owns 37,213 shares of the business services provider’s stock worth $1,598,000 after buying an additional 970 shares during the period. Burney Co. lifted its position in shares of Genpact by 242.8% in the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock valued at $5,618,000 after acquiring an additional 92,641 shares in the last quarter. Tealwood Asset Management Inc. boosted its stake in shares of Genpact by 1.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 24,658 shares of the business services provider’s stock worth $1,059,000 after acquiring an additional 339 shares during the period. Birch Capital Management LLC grew its position in shares of Genpact by 22.4% during the fourth quarter. Birch Capital Management LLC now owns 114,082 shares of the business services provider’s stock worth $4,900,000 after purchasing an additional 20,866 shares in the last quarter. Finally, Everence Capital Management Inc. bought a new stake in Genpact during the 4th quarter valued at approximately $210,000. 96.03% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of analysts have issued reports on G shares. Needham & Company LLC lifted their price target on shares of Genpact from $42.00 to $55.00 and gave the company a “buy” rating in a report on Monday, November 11th. Robert W. Baird raised their price objective on Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Finally, TD Cowen boosted their target price on Genpact from $40.00 to $45.00 and gave the stock a “hold” rating in a research report on Friday, November 8th. Eight equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, Genpact currently has an average rating of “Hold” and a consensus target price of $42.33.
Insiders Place Their Bets
In other news, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at $6,475,125.06. This represents a 7.35 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of $44.60, for a total transaction of $606,560.00. Following the completion of the transaction, the chief executive officer now directly owns 267,404 shares in the company, valued at $11,926,218.40. This trade represents a 4.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 35,058 shares of company stock worth $1,558,675. Corporate insiders own 2.80% of the company’s stock.
Genpact Price Performance
Shares of G opened at $45.13 on Tuesday. The firm has a market capitalization of $7.96 billion, a PE ratio of 12.40, a price-to-earnings-growth ratio of 1.43 and a beta of 1.18. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85. The company’s fifty day moving average price is $44.41 and its 200-day moving average price is $39.87. Genpact Limited has a 1-year low of $30.23 and a 1-year high of $47.98.
About Genpact
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also
- Five stocks we like better than Genpact
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Health Care Stocks Explained: Why You Might Want to Invest
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Compound Interest and Why It Matters When Investing
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.